- HilleVax Inc.
HilleVax Inc.
75 State Street
Website
Offer Price
Offer Size
3-Year Outlook
Volatility
1st Day Turnover
$17.00
11,770,000
Positive
High
19.86%
Offering Team
Deal Managers
- J P Morgan Chase
- SVB Leerink
- Stifel
Lawyers
- Davis Polk & Wardwell LLP
Auditors
- Ernst & Young LLP
Pre-IPO Investors
Investors
- Google Ventures
- Intel Ventures
- Patricoff Ventures
- Kleiner Perkins
Pre-IPO Holdings(%)
- 30
- 20
- 05
- 18
Deal Highlights
We are founded on the legacies of leading vaccine developers who inspire us to build a company to benefit human health on a global scale. Our late co-founder, Dr. Tadataka “Tachi” Yamada, championed vaccines as a powerful means to address health inequities and equalize opportunity for people around the world. As the former Chief Medical and Scientific Officer at Takeda Pharmaceutical Company Limited (Takeda Pharmaceuticals), Tachi helped establish Takeda Pharmaceuticals More
Deal Tracker
Investors
Filing
28 Apr, 2022Offer
29 Apr, 2022Look Ahead
Lock Up Expiry
29 Oct, 2022Earning
Nov 1, 2018IPO Terms
Offer Price | $17.00 |
Offer Size | 11M |